| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5943916 | Atherosclerosis | 2015 | 28 Pages |
Abstract
ERN produced a beneficial reduction in plasma apoB. The enrichment of LDL with apoE and apoA1 was unique to the Combo group and might be beneficial owing to the atheroprotective properties of apoE and HDL2 (a likely source of apoA1 in LDL fraction). The effect of therapies on the apoC3 glycosylation index is a novel finding, the implications of which will require further study.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Olga V. Savinova, Kristi Fillaus, William S. Harris, Gregory C. Shearer,
